Persistence of the Epstein–Barr Virus and the Origins of Associated Lymphomas

Kieff E, Rickinson AB. Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, eds. Fields virology. 4th ed. Vol. 2. Philadelphia: Lippincott Williams & Wilkins, 2001:2511-73.

Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, eds. Fields virology. 4th ed. Vol. 2. Philadelphia: Lippincott Williams & Wilkins, 2001:2575-627.

Thorley-Lawson DA. Epstein-Barr virus. In: Austen KF, Frank MM, Atkinson JP, Cantor H, eds. Sampter's immunologic diseases. 6th ed. Vol. 2. Philadelphia: Williams & Wilkins, 2001:970-85.

10.1016/S0024-3205(99)00214-3

10.1038/35095584

Khanna R, 1997, J Virol, 71, 8340, 10.1128/JVI.71.11.8340-8346.1997

Diehl V, 1968, J Virol, 2, 663, 10.1128/JVI.2.7.663-669.1968

10.1002/ijc.2910030619

10.1016/S1074-7613(00)80622-6

Miyashita EM, 1997, J Virol, 71, 4882, 10.1128/JVI.71.7.4882-4891.1997

10.1073/pnas.2237267100

10.1016/S1074-7613(00)00049-2

10.1128/JVI.74.21.9964-9971.2000

10.1084/jem.190.4.567

Henle W, Henle G. Seroepidemiology of the virus. In: Epstein MA, Achong BG, eds. The Epstein-Barr virus. Berlin, Germany: Springer-Verlag, 1979:61-78.

Joncas J, 1974, Can Med Assoc J, 110, 33

10.1001/jama.203.3.205

10.1126/science.1076071

10.1111/j.1600-065X.1997.tb00963.x

10.1146/annurev.iy.12.040194.001001

MacLennan IC, 1988, Curr Top Microbiol Immunol, 141, 138

Thorley-Lawson DA, 1985, J Immunol, 134, 3007, 10.4049/jimmunol.134.5.3007

10.1016/0092-8674(82)90239-2

Nilsson K. The nature of lymphoid cell lines and their relationship to the virus. In: Epstein MA, Achong BG, eds. The Epstein-Barr virus. Berlin, Germany: Springer-Verlag, 1979:225-81.

10.1073/pnas.200366597

10.1093/emboj/17.6.1700

10.1016/S1074-7613(00)80623-8

10.1038/ni1036

10.1016/S1074-7613(02)00318-7

10.1038/313812a0

Pearson G, 1970, J Natl Cancer Inst, 45, 989

10.1111/j.1600-065X.1999.tb01328.x

10.1084/jem.187.9.1395

10.1016/0002-9343(67)90073-3

10.1038/354453a0

10.1038/296115a0

10.1073/pnas.2627966100

10.1016/S1074-7613(00)00048-0

10.1126/science.286.5438.300

10.1073/pnas.87.19.7390

Wang F, 1990, J Virol, 64, 3407, 10.1128/JVI.64.7.3407-3416.1990

10.1038/nm830

10.1038/nm0602-594

10.1056/NEJM200008173430707

10.1098/rstb.2000.0783

Joseph AM, 2000, J Immunol, 165, 2975, 10.4049/jimmunol.165.6.2975

10.1136/jcp.53.4.248

10.1097/00007890-199005000-00022

10.1016/S0140-6736(03)12271-4

Anagnostopoulos I, 1995, Blood, 85, 744, 10.1182/blood.V85.3.744.bloodjournal853744

10.1056/NEJM198902233200806

10.1002/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T

10.1056/NEJMoa023141

10.1136/jcp.49.11.897

10.1084/jem.177.2.339

10.1073/pnas.88.11.4766

Niedobitek G, 1997, Blood, 90, 1664, 10.1182/blood.V90.4.1664

10.1146/annurev.immunol.16.1.471

10.1084/jem.191.2.207

10.1016/S0140-6736(64)91524-7

10.1016/0092-8674(83)90449-X

Leder P. Translocations among antibody genes in human cancer. In: Lenoir GM, O'Conor GT, Olweny CLM, eds. Burkitt's lymphoma: a human cancer model. Lyons, France: International Agency for Research on Cancer, 1985:341-71. (IARC publications no. 60.)

10.1038/237033a0

Klein U, 1995, Mol Med, 1, 495, 10.1007/BF03401587

Gregory CD, 1987, J Immunol, 139, 313, 10.4049/jimmunol.139.1.313

de-Thé G. Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited. In: Lenoir GM, O'Conor GT, Olweny CLM, eds. Burkitt's lymphoma: a human cancer model. Lyons, France: International Agency for Research on Cancer, 1985:165-76. (IARC publications no. 60.)

10.1002/1097-0142(19920701)70:1<185::AID-CNCR2820700129>3.0.CO;2-J

Lenoir GM, Bornkamm GW. Burkitt's lymphoma, a human cancer model for the study of the multistep development of cancer: proposal for a new scenario. In: Klein G, ed. Advances in viral oncology. Vol. 7. New York: Raven Press, 1987:173-206.

Klein G. In defense of the “old” Burkitt lymphoma scenario. In: Klein G, ed. Advances in viral oncology. Vol. 7. New York: Raven Press, 1987:207-11.

10.1038/nm758

10.1099/0022-1317-71-7-1481

10.1073/pnas.93.19.10411